Malarial Cytokine Responses Reduced by Age in Exposed Children
|
By LabMedica International staff writers Posted on 10 Jan 2018 |

Image: The MAGPIX CCD Imager, a compact multiplexing unit (Photo courtesy of Luminex).
Elevated levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute malaria infection contribute to the control of parasitemia, but are also responsible for much of the immunopathology seen during symptomatic disease.
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity.
An international team of scientists working with those at University of California San Francisco (CA, USA) obtained blood samples from study cohort that was initiated in 2011 and is ongoing. This cohort consists of 100 households where malaria transmission in this region is holoendemic, with an annual entomological inoculation rate (EIR) of 310 infective bites per person year. In total, plasma samples from 48 children were analyzed: 25 from children 1 to 3 years old and 23 from children 7 to 10 years old.
Thick blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were evaluated for the presence of parasitemia (asexual forms only) and gametocytes. The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology. Fourteen cytokines and six chemokines were analyzed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit and read on a Luminex MAGPIX CCD Imager. Human interferon gamma (IFNγ) OptEIA ELISA II Kits were used to quantify IFNγ levels in plasma.
The team found that younger children presenting with acute malaria exhibited much higher levels of tumor necrosis factor (TNF), interleukin-2 (IL2), and IL6, as well as increased T helper cells (Th1) associated chemokines interferon gamma-induced protein 10 (IP10), Monokine induced by gamma interferon (MIG), and monocyte chemoattractant protein-1 (MCP1), was compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and tumor necrosis factor receptor 1 (TNFRI) were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
The authors concluded that that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travelers; however, they also show increased levels of the regulatory cytokines IL10 and soluble TNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. The study was published on December 29, 2017, in the Malaria Journal.
Related Links:
University of California San Francisco
Latest Microbiology News
- Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
- Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria
- Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
- Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
- Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections
- Antibiotic Resistance Genes Found in Newborns Within Hours of Birth
- Rapid Color Test Stratifies Virulent and Resistant Staph Strains
- mNGS CSF Test Identifies CNS Pathogens Missed by Standard Panels
- Syndromic Panel Enables Rapid Identification of Bloodstream Infections
- RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
- Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots
- New Bacterial Target Identified for Early Detection of Noma
- Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
- Rapid Urine Test Speeds Antibiotic Selection for UTIs
- WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
Immunotherapy has transformed cancer care, yet durable benefit remains limited to a subset of patients, and clinicians still lack reliable tools to predict response before treatment begins.... Read more
Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
Respiratory infections drive heavy testing volumes in clinical laboratories, where accurate, timely results across multiple pathogens are essential. Many labs are seeking to streamline workflows and increase... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read more
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Early diagnosis remains the most effective way to reduce cancer mortality, yet many screening tools miss disease at its earliest stages. Biomarkers shed by tumors into blood and other fluids can be scarce... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more








